The California stem cell agency this
week mentioned the hiring of a business development officer as part
of its plan to engage industry more robustly but did not identify
him.
|
Neil Littman Linked In photo |
The California Stem Cell Report queried
the agency about the new hire. Kevin McCormack, the agency spokesman,
identified him as Neil Littman, who most recently worked as a senior
associate in the merchant banking group at Burrill & Co. in San
Francisco.
Littman's responsibilities will include
“facilitating opportunities for outside investment in stem cell
research in California for both CIRM-funded and non CIRM-funded
programs by biopharmaceutical strategic partners, equity investors and disease foundations.”
McCormack said that Littman's
“strategic advisory experience includes buy-side and sell-side M&A,
as well as in-licensing and out-licensing of both development stage
and commercial products.”
Littman also worked at Thomas Weisel
Partners and at Deutsche Bank Securities. He received a M.S. in biotechnology with a concentration in biotechnology enterprise from The Johns Hopkins University, and a B.A. in molecular, cellular and development biology from the University of
Colorado Boulder in 2002.
Littman's salary at CIRM is $160,000 annually.
Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/ZZklmGcLX8Q/neil-littman-new-business-development.html
Recommendation and review posted by G. Smith